Advanced search
Publication Cover
Renal Failure Volume 38, 2016 - Issue 5
Submit an article Journal homepage
807
Views
1
CrossRef citations to date
0
Altmetric
Clinical Study

Safety and efficacy of mizoribine treatment in nephrotic syndrome complicated with hepatitis B virus infection: a clinical study

Jishi LiuDivision of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China
,
Ke ZhangDivision of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China
,
Ying JiDivision of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China
,
Wei ZhangDivision of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China
,
Wei LiDivision of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China
,
Qing YongDivision of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China
,
Jianwen WangDivision of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China
,
Jian SunDivision of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China
&
Hao ZhangDivision of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, ChinaCorrespondence[email protected]
 show all
Pages 723-727 | Received 09 Nov 2015, Accepted 17 Feb 2016, Published online: 16 Mar 2016

References

  • Bixin T, Jianjie C. Antiviral treatment status of Chronic hepatitis B. Chin J Compos Clin Med (in Chinese) 2004;6:128–132.
  • Ekberg H, Bernasconi C, Nöldeke J, et al. Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study. Nephrol Dial Transplant. 2010;25:2004–2010.
  • Baek CH, Yang WS, Park KS, et al. Infectious risks and optimal strength of maintenance immunosuppressants in rituximab-treated kidney transplantation. Nephron Extra. 2012;2:66–75.
  • Chertoff J, Alam S, Black M, et al. Azathioprine-induced hepatitis and cholestasis occurring 1 year after treatment. BMJ Case Rep. 2014;2014. doi: 10.1136/bcr-2014-206859.
  • Kusmi T, Tsuda M, Katsumura T, et al. Dual inhibitory effect of bredinin. Cell Biochem Funct. 1989;7:201–204.
  • Syokota S. Mizoribine: Mode of action and effects in clinical use. Pediatr Int. 2002;44:196–198.
  • Kawasaki Y. Mizoribine: A new approach in the treatment of renal disease. Clin Dev Immunol. 2009;2009:684182.
  • Shibasaki T, Koyama A, Hishida A, et al. A randomized open-label comparative study of conventional therapy versus mizoribine on lay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey). Clin Exp Nephrol. 2004;8:117–126.
  • Kawasaki Y, Hosoya M, Kobayashi S, et al. Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome. Nephrol Dial Transplant. 2005;20:2243–2247.
  • Yunmra W, Suqanuma S, Uchida K, et al. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis. Clin Nephrol. 2005;64:28–34.
  • Kaneko K, Nagaoka R, Ohtomo Y, et al. Mizoribine for childhood IgA nephropathy. Nephron. 1999;83:376–377.
  • Kawasaki Y, Hosoya M, Suzuki J, et al. Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy. Am J Nephrol. 2004;24:576–581.
  • Xie YS, Huang SM, Wang L, et al. Efficacy and safety of mizoribine combined with losartan in the treatment of IgA nephropathy: A multicenter, randomized, controlled study. Am J Med Sci. 2011;341:367–372.
  • Nagaoka R, Kaneko K, Yamashiro Y, et al. Mizoribine treatment for childhood IgA nephropathy. Pediatr Int. 2002;44:217–223.
  • Hara S, Umino D, Someya T, et al. Protective effects of mizoribine on cyclosporine a nephropathy in rats. Pediatr Res. 2009;66:524–527.
  • Ikezumi Y, Suzuki T, Karasawa T, et al. Contrasting effects of steroids and mizoribine on macrophage activation and glomerular lesions in rat thy-1 mesangial proliferative glomerulonephritis. Am J Nephrol. 2010;31:273–282.
  • Matsumoto Y, Shimada Y, Nojima Y, et al. Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria. Ren Fail. 2013;35:936–941.
  • Tanaka H, Tsugawa K, Nakahata T, et al. Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome. Tohoku J Exp Med. 2005;205:87–91.
  • Liu S, Xie Y, Lv Y, et al. A novel target of mizoribine inhibiting mesangial cell proliferation: S phase kinase-associated protein 2. Am J Nephrol. 2010;32:447–455.
  • Fufang Q, Lei Y, Qiying F, et al. The inhibitory effect of mizoribine on mesangial cell proliferation in anti-Thy1 mesangial proliferative nephritis. J Pract Diagnosis Therapy (in Chinese) 2011;25:1185–1187.
  • Nakajo A, Khoshnoodi J, Takenaka H, et al. Mizoribine corrects defective nephrin biogenesis by restoring intracellular energy balance. J Am Soc Nephrol. 2007;18:2554–2564.
  • Naka K, Ikeda M, Abe K, et al. Mizoribine inhibits hepatitis C virus RNA replication: Effect of combination with interferon-alpha. Biochem Biophys Res Commun. 2005;330:871–879.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.